Michael Sension - Concepedia

Author

Michael Sension

Also Known As

A. Scarsella, M Sension, M. G. Sension, MICHAEL G. SENSION, Michael G Sension, Michael G. Sension, Michael Sension, Robert Schwartz

Publications

Citations

H-Index

Concepts

All Affiliations

Broward Health Research Triangle Park Foundation GlaxoSmithKline (United States)AIDS Healthcare Foundation Atrium Medical Cente

About

Michael Sension is an author at Broward Health specializing in medicine, pharmacotherapy, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	343
2	Public Health	3	3	101
3	Language Studies	1	1	44
4	Biochemistry	1	1	18
5	Comparative Literature	1	1	44

Michael Sension

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Comparison of Once-Daily Atazanavir With Efavirenz, Each in Combination With Fixed-Dose Zidovudine and Lamivudine, As Initial Therapy for Patients Infected With HIV Kathleen Squires, Adriano Lazzarin, Jos M. Gatell, JAIDS Journal of Acquired Immune Deficiency Syndromes	2004	299
A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy Calvin Cohen, Susan C. Hunt, Michael Sension, AIDS	2002	197
Improvement in Lipoatrophy Associated with Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus–Infected Patients Switched from Stavudine to Abacavir or Zidovudine: The Results of the TARHEEL Study Grace A. McComsey, Douglas Ward, Siegrid M. Hessenthaler, Clinical Infectious Diseases	2004	187
Long-Term Efficacy and Safety of Atazanavir With Stavudine and Lamivudine in Patients Previously Treated With Nelfinavir or Atazanavir Robin Wood, Praphan Phanuphak, Pedro Cahn, JAIDS Journal of Acquired Immune Deficiency Syndromes Long-term EfficacyPharmacotherapyAntiviral DrugAdverse Drug ReactionHiv/aids Counselling	2004	102
Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial David W. Haas, Carlos Zala, Shannon Schrader, AIDS	2003	95
Vitamin A Levels and Mortality Among Hospitalized Measles Patients, Kinshasa, Zaire Lauri E. Markowitz, Nzila Nzilambi, William J. Driskell, Journal of Tropical Pediatrics Hospitalized Measles PatientsPreventive MedicineMeasles MortalityEpidemiological OutcomeEpidemiologic Research	1989	64
Lipid Levels and Changes in Body Fat Distribution in Treatment-Naive, HIV-1–Infected Adults Treated With Rilpivirine or Efavirenz for 96 Weeks in the ECHO and THRIVE Trials Pablo Tebas, Michael Sension, José Ramón Arribas, Clinical Infectious Diseases	2014	63
Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511) Michael S. Saag, Pablo Tebas, Michael Sension, AIDS	2001	61
Once-Daily versus Twice-Daily Lamivudine, in Combination with Zidovudine and Efavirenz, for the Treatment of Antiretroviral-Naive Adults with HIV Infection: A Randomized Equivalence Trial E DeJesus, Dennis McCarty, Charles Farthing, Clinical Infectious Diseases ImmunodeficienciesWeek 48ImmunologyPharmacotherapyAntiviral Drug	2004	60
PREVALENCE OF HYPERLIPIDEMIA IN HEART TRANSPLANT RECIPIENTS Diane M. Becker, Maria Markakis, Michael Sension, Transplantation Author InformationLiterary HistoryIntellectual HistoryTransplantationComparative Literature	1987	44

Page 1